Director, Global Health Economics & Outcomes Research jobs in United States
cer-icon
Apply on Employer Site
company-logo

Madrigal Pharmaceuticals · 7 hours ago

Director, Global Health Economics & Outcomes Research

Madrigal Pharmaceuticals is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH). The Director, Global Health Economics & Outcomes Research will lead the GHEOR strategy to optimize patient access, pricing, and reimbursement for Madrigal's medicines, particularly focusing on evidence generation and market access initiatives.

BiopharmaBiotechnologyMedical DevicePharmaceutical

Responsibilities

Lead the evidence generation strategy for Rezdiffra with HQ-based stakeholders in partnership with the cross-functional matrix team
Integrate input from US and international teams into a comprehensive evidence strategy to support market access, reimbursement, and lifecycle management
Design and execute HEOR studies including network meta-analyses and real-world studies, from concept through publication
Develop launch and HTA deliverables such as value dossiers, systematic literature reviews, economic models, and innovative tools to support payer engagement, reimbursement, and access
Provide strategic input into clinical trial design to support payer and regulatory decisions
Partner with internal stakeholders to ensure appropriate dissemination of HEOR materials per regulatory guidance and internal SOPs
Develop strategic partnerships and research collaborations with key external experts healthcare policymakers payers and academic and community oncology settings to support asset strategies
Support the GHEOR budget planning forecasting and allocation to ensure efficient use of resources across US and international initiatives
Manage external vendor contracts and timelines to ensure project deliverables are completed on time within scope and within budget
Foster continuous development through mentoring and training
Align Publications activities with strategic objectives and tactical plans
Ensure all activities comply with company SOPs, industry standards, and applicable regulations
Uphold the highest ethical standards in all external engagements
Willingness to travel up to 30%, primarily in the US, with occasional international travel for conferences or collaboration with all GHEOR teams
Ability to work across international time zones as needed

Qualification

Health EconomicsHealth Technology AssessmentReal-World EvidenceEconomic ModelingStatistical AnalysisProject ManagementInterpersonal SkillsBudget ManagementCommunication SkillsTeam LeadershipProblem-SolvingCollaborationMentoring

Required

Graduate degree in health economics, epidemiology, health services research, or a related field
12-15+ years of HEOR or related experience with 7+ years with PhD
Direct experience with US health technology assessment (HTA) and value assessment bodies (e.g., ICER) and familiarity with select international HTA agencies (e.g., NICE, CADTH)
Deep expertise in health services research methods, including economic modeling, patient-reported outcomes (PROs), statistics, and real-world evidence studies
Proven ability to independently design, execute, and manage complex non-interventional studies in the US and internationally
Strong understanding of the US drug development process and payer landscape
Excellent interpersonal and influencing skills to engage multiple internal and external stakeholders across cross-functional and matrixed teams
Execution-focused and highly organized, with strong project management skills in budgeting, contracting, vendor oversight, and the ability to manage multiple priorities under tight timelines
Exceptional written and verbal communication skills in English, with experience preparing technical and value-based materials for diverse audiences
Demonstrated ability to assess and prioritize projects based on business value, with a proactive approach to problem-solving and adapting to change
High proficiency with project management systems, Medical Affairs dashboards, CRM platforms, and enterprise collaboration tools (e.g., Veeva, Microsoft Office Suite, SharePoint, Teams, Zoom)

Preferred

In-depth knowledge of liver disease; experience in cardiometabolic health or Metabolic Dysfunction-Associated Steatohepatitis
PhD degree in health economics, epidemiology, health services research, or a related field
International mobility
Experience supporting international launch

Benefits

Flexible paid time off
Medical
Dental
Vision and life/disability insurance
401(k) offerings (i.e., traditional, Roth, and employer match)
Supplemental life insurance
Legal services
Mental health benefits through our Employee Assistance Program for employees and their family

Company

Madrigal Pharmaceuticals

twittertwittertwitter
company-logo
Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.

Funding

Current Stage
Public Company
Total Funding
$1.94B
Key Investors
Blue OwlHercules Capital
2025-07-22Post Ipo Debt· $350M
2024-03-18Post Ipo Equity· $690M
2023-09-28Post Ipo Equity· $500M

Leadership Team

leader-logo
Mardi C. Dier
Chief Financial Officer
linkedin
leader-logo
Carole Huntsman
Chief Commercial Officer (CCO)
linkedin
Company data provided by crunchbase